Cancer
Meda Launches Onsolis(TM) (Fentanyl Buccal Soluble Film) for the Treatment of Breakthrough Cancer Pain in Opioid Tolerant Patients
Published in Cancer Weekly, October 27th, 2009
Meda Pharmaceuticals Inc. announced the launch of Onsolis™ (fentanyl buccal soluble film) in the U.S. for the management of breakthrough pain (BTP) in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. Onsolis uses an innovative drug delivery technology called BioErodible MucoAdhesive (BEMA™), developed by BioDelivery Sciences International, Inc. (BDSI). Onsolis consists of a small, dissolvable, polymer film, formulated with fentanyl, for application to the inner lining of the cheek.
Onsolis is available through a controlled distribution program...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-10-27)
More Articles from Cancer Weekly
- Harvard School of Public Health
Vaccinating boys against human papillomavirus not cost-effective - Mayo Clinic
Mayo researchers find few side effects from radiation treatment given after prostate cancer surgery - ArQule, Inc.
ArQule to Introduce Novel FGFR Inhibitor Program Discovered Through Its Proprietary Kinase Inhibitor Platform at AACR-NCI-EORTC Conference - Cancer
Canary Foundation Commits to Supporting New Platform for Cancer Diagnostics - Cancer
Statewide Teen Smoking-Cessation Trial is the First to Achieve Significant Increase in Prolonged Quit Rates - Cancer Gene Therapy
Research from Wayne State University in the area of cancer gene therapy published - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
